Washington:<Text>

US President Donald Trump decided to implement new tariffs on imported pharmaceutical products and critical metals to strengthen national security and domestic supply chains.

According to Anadolu Agency, the US administration implemented a 100% tariff on imported patented pharmaceutical products and ingredients, as stated by the White House on Thursday. This tariff rate is reduced to 15% for pharmaceutical imports originating from the EU, Japan, South Korea, Switzerland, and Liechtenstein. Pharmaceutical companies face a 20% tariff if they only sign domestic manufacturing agreements with the government. Officials have exempted generic pharmaceuticals, biosimilars, and orphan drugs from these immediate trade measures.

In a parallel move, the administration introduced a flat 50% tariff on articles made entirely or almost entirely of steel, aluminum, and copper. Derivative articles that substantially contain these three strategic metals will r eceive a flat 25% import penalty. The government has applied a temporary 15% tariff on specific metal-intensive industrial and electrical grid equipment until 2027. Foreign-manufactured goods made exclusively with American metals qualify for a reduced 10% tariff rate. Products containing 15% or less steel, aluminum, or copper are completely exempt from these new trade tariffs.